SBH
NOVT icon

Segall Bryant & Hamill’s Novanta NOVT Stock Holding History

Segall Bryant & Hamill’s Portfolio NOVT Stock Details NOVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17M Buy
104,860
+1,827
+2% +$264K 0.2% 182
2026
Q1 		$12.2M Sell
103,033
-5,315
-5% -$697K 0.17% 200
2025
Q4 		$12.9M Buy
108,348
+4,765
+5% +$543K 0.17% 195
2025
Q3 		$10.4M Buy
103,583
+2,529
+3% +$301K 0.14% 230
2025
Q2 		$13M Buy
101,054
+44,149
+78% +$5.37M 0.18% 183
2025
Q1 		$7.28M Sell
56,905
-1,623
-3% -$233K 0.11% 260
2024
Q4 		$8.94M Sell
58,528
-37,410
-39% -$6.33M 0.12% 243
2024
Q3 		$17.2M Sell
95,938
-3,915
-4% -$680K 0.23% 137
2024
Q2 		$16.3M Buy
99,853
+2,709
+3% +$439K 0.29% 114
2024
Q1 		$17M Sell
97,144
-1,395
-1% -$229K 0.32% 109
2023
Q4 		$16.6M Buy
98,539
+220
+0.2% +$32.1K 0.32% 111
2023
Q3 		$14.1M Sell
98,319
-624
-0.6% -$102K 0.16% 166
2023
Q2 		$18.2M Buy
98,943
+505
+0.5% +$82.6K 0.19% 143
2023
Q1 		$15.7M Buy
98,438
+1,229
+1% +$189K 0.17% 162
2022
Q4 		$13.2M Buy
97,209
+16,819
+21% +$2.35M 0.15% 186
2022
Q3 		$9.3M Buy
80,390
+23,717
+42% +$3.23M 0.11% 221
2022
Q2 		$6.87M Buy
56,673
+16,728
+42% +$2.1M 0.08% 260
2022
Q1 		$5.68M Buy
39,945
+100
+0.3% +$14.2K 0.05% 308
2021
Q4 		$7.03M Buy
39,845
+1,849
+5% +$309K 0.06% 260
2021
Q3 		$5.87M Buy
37,996
+1,007
+3% +$146K 0.06% 300
2021
Q2 		$4.99M Sell
36,989
-16,286
-31% -$2.19M 0.05% 335
2021
Q1 		$7.03M Buy
53,275
+17,933
+51% +$2.36M 0.07% 271
2020
Q4 		$4.18M Sell
35,342
-660
-2% -$77K 0.05% 320
2020
Q3 		$3.79M Buy
36,002
+26,073
+263% +$2.76M 0.05% 299
2020
Q2 		$1.06M Buy
9,929
+402
+4% +$37.4K 0.02% 423
2020
Q1 		$762K Sell
9,527
-1,069
-10% -$95.5K 0.02% 496
2019
Q4 		$936K Sell
10,596
-784
-7% -$67.6K 0.01% 533
2019
Q3 		$930K Buy
+11,380
New +$925K 0.01% 532

Other funds holding NOVT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Segall Bryant & Hamill's NOVT Position: Q2 2026 in Review

Segall Bryant & Hamill increased its Novanta (NOVT) stake by 1.8% in Q2 2026, buying an estimated $264K and bringing the position to 104,860 shares worth $17M. The position accounts for 0.2% of the portfolio, ranked #182.

Segall Bryant & Hamill first reported a position in NOVT in Q3 2019 and has held it in 28 quarters since. The position peaked at $18.2M in Q2 2023. 389 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

  • Segall Bryant & Hamill held 104,860 shares of Novanta worth $17M as of Q2 2026.
  • Segall Bryant & Hamill bought 1,827 Novanta shares in Q2 2026, an estimated $264K.
  • Novanta made up 0.2% of Segall Bryant & Hamill's portfolio in Q2 2026, its #182 holding.
  • Segall Bryant & Hamill first reported a position in Novanta in Q3 2019 and has held it in 28 quarters since.
  • Segall Bryant & Hamill's Novanta position peaked at $18.2M in Q2 2023.
  • 389 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.